BioSpace News Archive

Drug Development

Pasithea Therapeutics Announces Completion of GMP Manufacturing for PAS-004-- Represents the final step before submission of Investigational New Drug (IND) application to FDA

Pasithea Therapeutics Corp. today announced it has successfully completed manufacturing of GMP-compliant Phase 1 clinical supplies of the active pharmaceutical ingredient (“API”) of its lead product candidate PAS-004.

June 29, 2023
·
5 min read
Pharm Country

National Cancer Center Announces Recipients of 2023-24 Research Fellowship Awards

The National Cancer Center is pleased to announce the recipients of its 2023-24 research grant awards, which support research fellows pursuing promising and innovative cancer research.

June 29, 2023
·
3 min read
Business

Ironwood and VectivBio Announce the Completion of the Tender Offer for VectivBio Shares

Ironwood Pharmaceuticals, Inc. (“Ironwood”) (Nasdaq: IRWD), a GI-focused healthcare company, and VectivBio Holding AG today announced the successful completion of the tender offer to purchase the outstanding ordinary shares of VectivBio (the “Shares”) for $17.00 per share.

June 29, 2023
·
6 min read
Biotech Bay

Geron Announces U.S. Expanded Access Protocol for Imetelstat in Lower Risk MDS

Geron Corporation (Nasdaq: GERN), a late-stage clinical biopharmaceutical company, today announced that an Expanded Access Protocol (EAP) is available for imetelstat, the Company’s first-in-class telomerase inhibitor.

June 29, 2023
·
7 min read
Bio NC

IQVIA selected ‘Leader’ in Everest Group Life Sciences Sales and Marketing Operations PEAK Matrix® Assessment 2023

IQVIA™, a global provider of data, analytics, technology solutions and services to the life sciences industry, was recognized as the highest scoring provider in the ‘Leader’ category of Everest Group’s Life Sciences Sales and Marketing Operations PEAK Assessment.

June 29, 2023
·
3 min read
Business

Organicell Welcomes Howard Golub, MD, PhD As Its New EVP/CSO

Organicell Regenerative Medicine, Inc . is pleased to announce the appointment of Howard L. Golub, MD, PhD as its new Executive Vice President (EVP) and Chief Science Officer (CSO).

June 29, 2023
·
4 min read
Pharm Country

Aquestive Therapeutics Provides Business Update and Announces Chief Medical Officer Appointment

Aquestive Therapeutics, Inc. today provided an update on recent business developments and announced the appointment of Carl N. Kraus, M.D. as Chief Medical Officer of the Company.

June 29, 2023
·
11 min read
Chinese Neurosurgical Journal Outlines the Potential for Network Neurosurgery in the Twenty-First Century

As the field of neurosurgery nears its centennial, it is spurred on by the introduction of digitized medical imaging, hybrid operating rooms, and advanced brain research.

June 29, 2023
·
3 min read
Business

Alentis Therapeutics Appoints Luca Santarelli as Chairperson

Alentis Therapeutics announced today the appointment of Dr. Luca Santarelli as the Chair of its Board of Directors.

June 29, 2023
·
2 min read
Business

GE HealthCare to Announce Second Quarter 2023 Results on July 25, 2023

GE HealthCare (Nasdaq: GEHC), a leader in precision care innovation, will announce its second quarter 2023 financial results before the market opens on Tuesday, July 25, 2023.

June 29, 2023
·
1 min read